Search details
1.
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
Blood
; 140(24): 2533-2548, 2022 12 15.
Article
in English
| MEDLINE | ID: mdl-35969835
2.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Article
in English
| MEDLINE | ID: mdl-37021929
3.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35443559
4.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-36779595
5.
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
Br J Haematol
; 198(4): 785-789, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35658101
6.
Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes.
Transplant Cell Ther
; 2024 Jun 11.
Article
in English
| MEDLINE | ID: mdl-38871054
7.
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 29(10): 611-618, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37481243
8.
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia.
Transplant Cell Ther
; 29(9): 578.e1-578.e9, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37406882
9.
Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.
Transplant Cell Ther
; 29(8): 523-528, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37220838
10.
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
Blood Adv
; 7(12): 2746-2757, 2023 06 27.
Article
in English
| MEDLINE | ID: mdl-36827681
11.
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Blood Adv
; 7(15): 3993-4002, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37134306
12.
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.
Leukemia
; 36(5): 1227-1236, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35338251
13.
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation.
Transplant Cell Ther
; 28(2): 83.e1-83.e9, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34781066
14.
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.
Bone Marrow Transplant
; 57(1): 31-37, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34608275
15.
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
JAMA Oncol
; 8(3): 404-411, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-35024768
16.
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Blood Adv
; 6(1): 339-357, 2022 01 11.
Article
in English
| MEDLINE | ID: mdl-34547770
17.
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 28(4): 187.e1-187.e10, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35081472
18.
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden.
Transplant Cell Ther
; 27(3): 264.e1-264.e7, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33781533
19.
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.
Blood Cancer J
; 13(1): 170, 2023 11 15.
Article
in English
| MEDLINE | ID: mdl-37968258
20.
Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States.
Bone Marrow Transplant
; 58(12): 1400-1402, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37673983